After a long year of virtual meetings, the Society of Urologic Oncology (SUO) is looking forward to reconnecting with colleagues at the AUA in Las Vegas. Program chairs Dr. John Gore and Dr. Brian Cross have assembled an outstanding group of lecturers and topics this year.

As always, the SUO will co-host a morning program with the Society for Basic Urologic Research (SBUR) (Saturday, September 11 [7:55 am–11:00 am]). Co-chaired by Dr. Haojie Huang from SBUR and Dr. Jeffrey Holzbeierlein from SUO, the program is entitled, “Novel Strategies/Approaches for Urologic Disease Diagnosis and Treatment.” The first session starting at 8:00 a.m. is the “Don Coffey Lectureship: Artificial Intelligence for Healthcare: Opportunities and Challenges,” presented by Regina Barzilav, PhD, of the MIT Computer Science & Artificial Intelligence Lab. Following the lecture, several sessions exploring artificial intelligence in urological care will be presented. The second half of the program will be dedicated to PROTAC and cancer therapy.

The afternoon session (Saturday, September 11 [12:25 pm–5:00 pm]) begins with a celebration of contributions to the field of urologic oncology and the Society itself. The 2021 SUO Young Investigator Award will be presented to Dr. Sima Porten and Dr. Christopher Barbieri. The 2021 Distinguished Service Award will be presented to Dr. Michael Droller for his years of dedication to the Society’s journal, Urologic Oncology: Seminars and Original Investigations. And the SUO Medal will be presented to Dr. Seth Lerner. Congratulations to all award winners!

The award presentations will be followed by this year’s Whitmore Lecture, given by Dr. Peter Carroll. The Willet F. Whitmore Jr. Lectureship was established in 1993 as a tribute to Dr. Whitmore, who embodied the field of urologic oncology as a premier urological surgeon and as a pioneer in the multidisciplinary aspects of urological care. Dr. Peter Carroll was the longstanding chair of department of urology at the University of California, San Francisco from 1996 to 2020. Under his leadership, the department grew in size serving an increasingly larger patient population, expanded its research programs and attracted the future leaders in the field for training.

Additional topics on the agenda include sessions on biomarkers, neoadjuvant therapy and quality of life. A panel led by Dr. William Huang will review cases involving kidney surgery on bad kidneys, and Dr. Kelvin Moses will discuss current controversies in the management of high-risk prostate cancer. Other sessions will explore the impact of COVID-19 on the diagnosis of urological cancer and the use of telemedicine in practice. Returning this year are several sessions exploring papers that have changed practice. Please see the full schedule on the AUA Annual Meeting site (https://www.aua2021.org).

We would also like to invite you to attend the SUO’s 22nd Annual/Winter Meeting December 1–3, 2021 at the JW Marriott Orlando Grande Lakes, Orlando, Florida. Last year’s virtual conference was a success, and we are planning on incorporating the virtual encore platform again this year to enhance the experience for our in-person attendees, as well as provide the excellent scientific content to those who will be unable to travel. Please visit us at https://suonet.org/home.aspx for more information.